Mesothelioma Treatment: Understanding Cytoreductive Surgery and HIPEC

Mesothelioma Treatment: Understanding Cytoreductive Surgery and HIPEC

Peritoneal mesothelioma is a rare cancer linked to asbestos exposure. It’s aggressive. However, a promising option combines cytoreductive surgery (CRS) with hot chemotherapy (HIPEC). A new article explains the CRS and HIPEC procedures and details their role in mesothelioma treatment. What is Cytoreductive Surgery (CRS)? Cytoreductive surgery removes as much tumor as possible. For peritoneal mesothelioma, it targets visible cancer in the abdomen, including organs like the intestines, liver, and spleen. Extensive surgery is crucial. It often involves removing multiple organs to eradicate all cancer cells. This aims to reduce the tumor to a microscopic level, making treatments more effective. Patient selection is vital. Only those with good health and a disease extent that can handle major surgery are considered….

Surgical Procedures for Mesothelioma: Understanding Extrapleural Pneumonectomy for Sarcoma

Surgical Procedures for Mesothelioma: Understanding Extrapleural Pneumonectomy for Sarcoma

There are two common surgical procedures for mesothelioma: extrapleural pneumonectomy and pleurectomy decortication. Extrapleural pneumonectomy involves removing the lung affected by mesothelioma. Extrapleural pneumonectomy is a surgery. In it, part of the diaphragm and the linings of the lung and heart are also removed. This complex procedure is primarily performed in specialized centers. It is considered in cases of pleural-based sarcomas, among other conditions. Outcomes of Adult Patients: Key Findings A recent study described the characteristics and outcomes of adults who underwent extrapleural pneumonectomy for pleural-based sarcoma. Eight patients were included in the study. Primary outcomes were event-free survival and overall survival following the procedure. A study found that extrapleural pneumonectomy rarely cures adults with pleural-based sarcoma. Their median event-free…

Surgical Intervention in Pleural Mesothelioma: A Key to Improved Survival

Surgical Intervention in Pleural Mesothelioma: A Key to Improved Survival

Pleural mesothelioma is a rare, aggressive cancer with a poor prognosis. The impact of surgery on mesothelioma patient survival is unclear and sparking debate. A recent study was presented at the World Conference on Lung Cancer. It checked the survival of pleural mesothelioma. Some patients had chemotherapy treatments followed by surgery, while other patients skipped surgery. The aim of the study was to see if surgery could help mesothelioma patients live longer. The Impact of Surgery on Survival There are a variety of surgical procedures and treatments for pleural mesothelioma. The most recent study, from January 2011 to December 2021, included 296 patients. All were eligible for surgery after three cycles of chemotherapy with platinum plus pemetrexed. Among them, 272 had the…

Surgical Treatment Options for Mesothelioma
| |

Surgical Treatment Options for Mesothelioma

For some patients with mesothelioma, aggressive surgical treatment can help them live longer than other treatment options. This is the finding of a study published in the Journal of Thoracic and Cardiovascular Surgery. The authors focused on a specific type of surgery called “cytoreductive surgery” that is done in both the chest and belly area. Surgery Provides Hope for Cure Mesothelioma is a deadly cancer caused by asbestos exposure. The type of treatment for mesothelioma depends on many factors. The location of the cancer, the type of mesothelioma, and the health of the patient are some of these key factors. For patients who are healthy enough, surgery provides the best hope for a cure. Cytoreductive surgery is a type of…